Wedbush Downgrades Fusion Pharmaceuticals (FUSN) to Neutral

March 19, 2024 8:52 AM

Wedbush analyst David Nierengarten downgraded Fusion Pharmaceuticals (NASDAQ: FUSN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found